API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/shorla-oncology--eversana-announce-us-commercial-launch-of-fda-approved-jylamvo-the-first-and-only-oral-methotrexate-solution-approved-in-the-us-for-adults-302018960.html
https://endpts.com/sandoz-opens-two-new-facilities-gates-foundation-funds-needle-less-vaccines-novartis-expands-japanese-site/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2023-13847.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213362
https://www.onclive.com/view/nccn-issues-guideline-update-on-the-use-of-high-dose-methotrexate-glucarpidase-in-all-b-cell-lymphoma
https://www.reuters.com/business/healthcare-pharmaceuticals/us-seeks-new-suppliers-highly-used-cancer-drug-methotrexate-short-supply-2023-06-09/
https://timesofindia.indiatimes.com/city/hyderabad/life-threatening-bacteria-found-in-hyderabad-companys-cancer-drug-who/articleshow/99043682.cms?from=mdr
https://health.economictimes.indiatimes.com/news/pharma/methotrexate-use-is-linked-to-an-increased-risk-of-skin-cancer-study/97737152
https://www.fiercebiotech.com/biotech/regimmune-touts-compelling-phase-2-data-stem-call-transplant-patients-readies-phase-3
https://www.biospectrumasia.com/news/25/21116/japan-approves-subcutaneous-injection-formulation-for-rheumatoid-arthritis.html
https://www.fiercepharma.com/pharma/horizons-krystexxa-gets-new-combo-indication-methotrexate-breathes-new-life-drug
https://www.globenewswire.com/news-release/2022/03/31/2413910/0/en/Assertio-Holdings-Inc-Partners-with-BlinkRx-to-Support-Healthcare-Providers-and-Patients-Utilizing-Otrexup-methotrexate-with-a-Unique-Patient-Access-Solution.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-2-2022-1643778781.pdf
https://www.prnewswire.com/news-releases/abbvie-expands-immunology-portfolio-in-the-european-union-with-the-european-commission-approval-of-skyrizi-risankizumab-for-the-treatment-of-adults-with-active-psoriatic-arthritis-301426412.html
http://www.pharmafile.com/news/590481/nice-approves-treatment-rheumatoid-arthritis
https://www.nice.org.uk/news/article/nice-recommends-several-treatment-options-to-help-thousands-with-moderate-rheumatoid-arthritis#:~:text=NICE%20has%20today%20(10th,for%20use%20within%20the%20NHS.
https://www.globenewswire.com/news-release/2021/06/07/2242674/0/en/Equillium-to-Collaborate-with-Oxford-University-and-Kennedy-Institute-of-Rheumatology-to-Investigate-Role-of-the-CD6-ALCAM-Pathway-and-Itolizumab-in-Rheumatic-Diseases.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-20-2021-1611205836.pdf
https://www.raps.org/news-and-articles/news-articles/2020/12/azurity-garners-opdp-untitled-letter-for-marketing
https://www.prnewswire.com/news-releases/initial-study-results-show-feasibility-of-outpatient-methotrexate-administration-with-planned-use-voraxaze-glucarpidase-during-covid-19-pandemic-301171687.html
https://acrabstracts.org/abstract/the-association-of-methotrexate-sulfasalazine-and-hydroxychloroquine-use-with-incident-fractures-in-postmenopausal-women-with-rheumatoid-arthritis-findings-from-the-womens-health-initiative/
https://www.gov.uk/drug-safety-update/methotrexate-once-weekly-for-autoimmune-diseases-new-measures-to-reduce-risk-of-fatal-overdose-due-to-inadvertent-daily-instead-of-weekly-dosing
https://www.businesswire.com/news/home/20200916005194/en/MIRROR-Open-Label-Trial-Data-Published-in-Journal-of-Rheumatology-Show-79-Percent-of-Patients-Achieved-a-Complete-Response-Using-KRYSTEXXA%C2%AE-pegloticase-injection-with-Methotrexate
https://www.newswire.ca/news-releases/health-canada-approves-tremfya-r-guselkumab-injection-a-first-in-class-selective-interleukin-il-23-inhibitor-for-active-psoriatic-arthritis-822702384.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214121
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214121
https://www.hikma.com/newsroom/article-i2953-hikma-launches-methotrexate-injection-usp-and-methotrexate-for-injection-usp/
https://www.biospace.com/article/releases/target-enrollment-reached-in-mirror-randomized-controlled-trial-evaluating-krystexxa-pegloticase-injection-co-prescribed-with-methotrexate-as-an-immunomodulator-to-enhance-response-rates-for-people-living-with-uncontrolled-gout/
https://www.fresenius-kabi.com/news/fresenius-kabi-enters-marketing-agreement-for-biosimilar-product
https://www.prnewswire.com/news-releases/study-underway-to-examine-the-planned-use-of-voraxaze-with-methotrexate-in-cns-lymphoma-301045797.html
https://markets.businessinsider.com/news/stocks/can-fite-completes-50-patient-enrollment-in-phase-iii-rheumatoid-arthritis-study-implements-interim-analysis-1028867348
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210454
https://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-receives-fda-approval-for-reditrex-product-line-300966976.html